Delivery Order SPE2DB24D2205-SPE2DB25FEGFQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for COMBIPATCH 0.05-0.14 mg patches in a quantity of 8 units. This is a firm fixed price delivery order with a ceiling value of $1,743.72 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $630 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen will supply 8 boxes of the 0.05-0.14 mg dosage patches to fulfill requirements under the agency's pharmaceutical products contract vehicle. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 7-8, 2023. The firm fixed price contract has no set aside...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency Troop Support Medical awarded a $493,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561584493 COMBIPATCH 0.05-0.14 MG PTCH 8S. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The order is to provide transdermal combination hormone replacement patches and runs from July 24, 2023 through July 25, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.06 to AmerisourceBergen Drug Corp for CombiPatch 0.05-0.14 mg transdermal patches (8-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside award, meaning it was competitively awarded without restrictions to small businesses or other designated groups. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $985 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. The patches will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one-day period of performance from August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
- The Defense Logistics Agency Troop Support Medical awarded a $315 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 8 units of Combipatch transdermal patches (0.05-0.14 mg). The delivery order was issued against an existing Prime Vendor contract vehicle and has a period of performance from September 6-7, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency Troop Support Medical awarded a $428,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561412449 COMBIPATCH 0.05-0.14 MG PTCH 8S. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 5, 2023 through July 6, 2023 to supply transdermal combination hormone patches for the Department of Defense. No major subcontractors or set aside designations...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGFQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,231.17 in Combipatch transdermal patches (0.05-0.14 mg), with an ultimate completion date of August 15, 2025. This competitive award, issued on August 14, 2025, carries a firm fixed price structure and involves no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and related healthcare systems. The company maintains an extensive portfolio of competitively awarded contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for hormone replacement therapy patches exemplifies the company's ongoing role in supplying pharmaceutical products to support military and veteran healthcare programs through DLA's flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/14/25 |